Locations:
Search
Primary results from the phase 3 ANDROMEDA study
Largest retrospective study to date confirms randomized trials
Plasma cell-targeted therapy helps patient with rare condition
Emerging multidisciplinary program seeks better care, outcomes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Largest retrospective series confirms the safety and tolerability
A study of patients with brain metastases treated with SRS
Online tool reveals characteristics that may increase recurrence risk
Psychosocial and downstream effects
Cancer recurrence after vaginal estrogen use is low
Removing malignancy while maintaining breast appearance
Advertisement
Advertisement